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Background: Prior to DIEP flap breast reconstruction, mapping the perforators of the lower 
abdominal wall using ultrasound, computed tomography angiography (CTA) or magnetic 
resonance angiography (MRA) reduces the risk of flap failure. This review aimed to investigate the 
additional potential benefit of a reduction in operating time. 
Methods: We systematically searched the literature for studies concerning adult women 
undergoing DIEP flap breast reconstruction, which directly compared the operating times and 
adverse outcomes for those with and without preoperative perforator mapping by ultrasound, CTA 
or MRA. Outcomes were extracted, data meta-analysed and the quality of the evidence appraised. 
Results: Fourteen articles were included. Preoperative perforator mapping by CTA or MRA 
significantly reduced operating time (mean reduction of 54 minutes [95% CI 3, 105], p=0.04), when 
directly compared to DIEP flap breast reconstruction with no perforator mapping. Further, 
perforator mapping by CTA was superior to ultrasound, as CTA saved more time in theatre (mean 
reduction of 58 minutes [95% CI 25, 91], p<0.001) and was associated with a lower risk of partial 
flap failure (RR 0.15 [95% CI 0.04, 0.6], p=0.007). All studies were at risk of methodological bias 
and the quality of the evidence was very low. 
Conclusions: The quality of research regarding perforator mapping prior to DIEP flap breast 
reconstruction is poor and although preoperative angiography appears save operative time, reduce 
morbidity and confer cost savings, higher quality research is needed.  
Registration: PROSPERO ID CRD42017065012 
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Introduction  
As the incidence of breast cancer continues to rise1, more women are undergoing mastectomy and 
breast reconstruction2. Autologous tissue breast reconstruction offers the greatest patient 
satisfaction3, so its use is gaining popularity worldwide4 with the deep inferior epigastric perforator 
(DIEP) flap evolving as the ideal choice for autologous reconstruction in suitable women. Breast 
reconstruction with DIEP flap(s) is associated with lower risks of adverse outcomes5, favourable 
donor site morbidity6–9, improved quality of life10, shorter hospital stay11,12, reduced postoperative 
pain13–15 and superior cosmetic results16, compared to breast reconstruction using other flaps and a 
substantially lower risk of failure when compared to implants5,17,18. 
 
To reduce the risk of complications and improve the efficiency of flap harvest, many surgeons use 
preoperative perforating mapping of the lower abdominal wall. Current options19 include: duplex 
ultrasound; computed tomography angiography (CTA) with intravenous iodinated contrast and 
magnetic resonance angiography (MRA) with intravenous gadolinium. Recent reviews have shown 
that perforator mapping significantly reduces the risks of total and partial flap failure20 as well as 
hospital stay21. Axial imaging with CTA/MRA also provides an opportunity to detect 
‘incidentalomas’ or occult recurrence19, which could substantially change management22–24. 
Further, Offodile and colleagues25 showed that perforator mapping by CTA was cost-effective 
given morbidity reductions and improved quality of life when compared to DIEP flap breast 
reconstruction without preoperative imaging, which is associated with higher risks of complication. 
However, to-date there is no reliable evidence that perforator mapping reduces operating time. 
Reducing operating time has the potential to confer considerable cost-savings, reduce morbidity 
and therefore, improve patient outcomes. 
 
We aimed to investigate the hypothesis that preoperative perforator mapping by ultrasound, CTA 
or MRA prior to DIEP flap breast reconstruction, reduces operating time. 
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Methods  
This review is registered on the PROSPERO database (CRD42017065012); it was designed and 
conducted in accordance with the Cochrane Handbook of Systematic Reviews26 and has been 
authored in accordance with the PRISMA checklist27. 
 
Search Strategy 
Both Medline and EMBASE were interrogated by two independent authors, using the NICE 
Healthcare Database (www.hdas.nice.org.uk) and the terms DIE?P.ti,ab OR ((((deep AND inferior) 
AND epigastric) AND artery) AND perforator).ti,ab AND Breast reconstruction.ti,ab OR 
mammoplasty.ti,ab AND imag*.ti,ab  OR map*.ti,ab OR plan*.ti,ab OR angiogr*.ti,ab OR C?T*.ti,ab 
OR computed AND tomography.ti,ab OR magnetic AND resonance.ti,ab OR MR*.ti,ab OR 
ultra?so*.ti,ab OR duplex.ti,ab OR doppler.ti,ab. No language restrictions were applied. This 
yielded 417 hits in EMBASE and 572 in Medline on 7th August 2017. Searches were de-duplicated 
and screened according to a customised and previously piloted in/out form, by two independent 
authors. The full texts of all potentially relevant articles were obtained in accordance with our 
protocol (available at https://www.crd.york.ac.uk) except for one which was unobtainable28. The 
reference lists for all screened articles were also scrutinised for potentially relevant papers. Final 
lists of included articles were compared and disagreements resolved by discussion.  
 
Study Selection Criteria 
This review considers adult women (over the age of 18 years) undergoing breast reconstruction 
after mastectomy, using the DIEP flap. We considered articles that directly compared the operating 
times of DIEP flap breast reconstructions with preoperative perforator mapping (by imaging with 
CTA, MRA or ultrasound) against those women undergoing surgery without preoperative perforator 
mapping. 
 
The primary outcome is the difference in operative time, measured in minutes. We considered total 
operative time, flap harvest time and any other (undefined) operating time reported as analogous 
because time savings due to the intervention (in a direct comparison study where all other factors 
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are constant) are likely to be due to reductions in the flap harvesting time. Further, time is a scaled 
outcome with ratio property, so between-group differences in flap harvest time will be equal to 
differences in total operative time again supporting the concept that pooling is acceptable. 
Observational research rarely generates similar baseline groups, so we planned to use adjusted 
estimates of operating time. Secondary outcomes included total flap failure (defined as failure 
which required removal of the entire flap) and partial flap failure (defined as failure of a portion of 
the flap which required debridement but not complete removal), recorded as binary outcomes. 
 
Data extraction 
We extracted details of the study design and the statistics for operating time, flap harvest time or 
any permutation of these alongside the frequency of total flap loss and partial flap loss. Where data 
was missing or unclear, we contacted the corresponding author by email and/or phone and if no 
reply was received, then 4 weeks later all authors were contacted in addition to re-contacting the 
corresponding author. 
 
Nineteen articles were eligible. Two conference abstracts29,30 were excluded for lack of data. Re-
publication of similar data was encountered twice: Masia and colleagues published four articles 
which appeared to contain similar data; their 2010 article31 was similar (albeit with a different 
sample size) to another article32 and two conference abstracts33 but all lacked the standard 
deviations for the mean times reported or p-values for the comparisons, which would have enabled 
back-calculation, so were excluded. Minqiang et al simultaneously published similar work in the 
English34 and Chinese35 literature in 2010, although the sample size in the latter article is slightly 
larger (56 vs. 44) and therefore, we have utilised the larger dataset in the meta-analyses and 
consulted both articles to assess the risk of methodological bias. 
 
Seven included articles omitted the standard deviations of the mean times reported in the 
published works; one group provided the missing data36 whilst the other was unable37 so we 
include data from their unilateral cases only. Missing standard deviations were imputed using the 
Cochrane RevMan Calculator.  
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Assessment of Bias 
The risk of methodological bias was assessed by two review authors independently, using the 
ROBINS-I tool38. Similarly, the overall quality of the evidence was independently assessed by two 
review authors using the GRADE tool39. 
 
Analysis 
We performed direct comparison meta-analyses using Review Manager® version 5 (The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2014) to calculate mean differences in operating 
time and relative risk ratios (RR) for adverse outcomes with 95% confidence intervals (CI), using 
the inverse variance and Mantel-Haenszel tests, respectively. Random-effects models were used 
for except one analysis, due to statistical heterogeneity as quantified by the I2 statistic. The 
patient/woman was the unit of analysis and not the flap40,41. Significance was set as 5%. There was 
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Results 
We included 14 articles35–37,42–44,21,45–50 (Figure 1), the characteristics of which are summarised in 
Table 1.  
 
Preoperative perforator mapping by CTA or MRA saved a mean of 54 minutes (95% CI 3 to 105 
minutes, Figure 2). However, there was significant statistical heterogeneity, all studies were at high 
risk of methodological biases and the quality of the evidence is very low (GRADE score +1; 
downgraded once for methodological concerns). 
 
Subgroup analyses in Figure 3 show that perforator mapping by CTA appears superior to 
ultrasound, given that CTA reduced operating time by a mean of 58 minutes (95% CI 25 to 91 
minutes). Again, there was significant statistical heterogeneity, all studies were at risk of 
methodological biases and the quality of the evidence is very low (GRADE score 0; downgraded 
once for methodological concerns and once for consistency). We performed a sensitivity analysis 
by removing studies at high risk of methodological bias42,36,44 and CTA remained superior to 
ultrasound (saving a mean of 72 minutes [95% CI 33, 112], p<0.001). 
 
The risk of total flap loss was not different between women who had perforator mapping by CTA or 
ultrasound (Figure 4). All studies were at risk of methodological biases and the quality of this 
evidence is very low (GRADE score +1; downgraded once for methodological concerns). 
 
The risk of partial flap loss was 80% lower when perforator mapping was performed by CTA (RR 
0.2 [95% CI 0.04 to 0.6]; Figure 5). A sensitivity analysis performed by removing the study34 at high 
risk of methodological bias strengthened this association, such that CTA perforator mapping again 
appeared to reduce the risk of partial flap loss. The absence of statistical heterogeneity improves 
the confidence in this estimate and justifies the choice for a fixed-effects model. However, the 
quality of the evidence is again very low (GRADE score +1; downgraded once for methodological 
concerns). 
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For bilateral DIEP flap breast reconstructions, perforator mapping with either CTA or MRA did not 
significantly alter operative time (mean difference of 34 minutes [95% CI 33, 101], p=0.32 favouring 
CTA). Similarly, operating time after perforator mapping with CTA was not different to ultrasound 
(mean difference 80 minutes [95% CI 11, 170], p=0.08 favouring CTA). There was insufficient data 
to perform meta-analysis of the risks of total or partial flap loss for women undergoing bilateral 
DIEP flap breast reconstruction. All included studies reporting the outcomes of bilateral 
reconstruction were at high risk of methodological bias and the quality of the evidence is very low 
(GRADE score +1; downgraded once for methodological concerns). 
 
Risk of bias 
All studies were at risk of methodological biases (Figure 6) and this limits the external validity of 
our findings. Our reasons for declaring some studies at high risk of bias in certain domains are as 
follows:  
 Five studies were missing standard deviations48,51,37,45,46 which prevents inference about the 
spread of data and required imputation for this review, which will bias the results towards 
no effect and as such, we designated these studies at high risk of bias due to missing data.  
 Casey et al42 tabulated baseline between-group differences but omitted the p-values from 
the following tests of proportion: operating surgeons A vs. B vs. C, unilateral vs. bilateral 
reconstructions and; immediate vs. delayed cases. We analysed these proportions and 
they represent significant baseline imbalances (p<0.001, p=0.005 and p=0.0001, 
respectively) which could confound the outcome. It is unclear why these comparisons were 
omitted, so we have graded this study at high risk of ‘bias due to confounding’ and ‘bias in 
the selection of reported results’.  
 Klasson et al44 was graded as high risk of ‘bias in selection of the reported results’ given 
that there was one case lost to follow-up in the CTA group but incomplete data is still 
reported, and one case in the ultrasound group was excluded as the operation was very 
long and designated an outlier.  
 We judged Minqiang et al to be at high risk of methodological bias in several domains. 
Three DIEPs were converted to SIEA/TRAM flaps but included in the DIEP group analyses 
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(which is reflected in the judgement of high risk of ‘bias in classicisation of the intervention’) 
and this may bias the outcome in favour of mapping because SIEA and TRAM flaps are 
typically easier (and so faster) to harvest. The duality of publications34,35 with differences in 
the published data which we have designated high risk of bias due to missing data and 
selective reporting.  
 Tong et al48 was judged to be at high risk of bias of misclassification of the intervention and 
deviation from the intended intervention because they stated that “patients who had CTA 
for the purpose of preoperative planning for free flap reconstruction but did not undergo 
surgery were included in this study” which could affect the outcome. 
 Significant baseline imbalances were the reason that Vargas et al50 was judged at high risk 
of bias due to confounding. Ideally, they would also have adjusted their estimates for 
baseline differences in a multivariable model. 
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Discussion 
This review highlights the paucity of high quality of research concerning perforator mapping prior to 
DIEP flap breast reconstruction. We have shown that perforator mapping prior to DIEP flap breast 
reconstruction by axial imaging (by CTA or MRA) may reduce operating time and the risk of partial 
flap loss, which is in keeping with the evolving literature, but concerns over the quality of the 
primary data means that the outcome is not reliable. 
 
Our meta-analyses suggest that preoperative perforator mapping saves approximately one hour in 
theatre. The importance of reducing operating time should not be underestimated because 
operating time is independently associated with increased risks of flap failure52–54, venous 
thromboembolic events55 and infection56. Therefore, preoperative identification of the dominant 
perforator supplying the flap may expedite flap harvest and such time savings could in-turn reduce 
the risks of adverse outcomes. A recent health economic review of CTA prior to DIEP flap breast 
reconstruction concluded that perforator mapping by CTA was more cost-effective than 
ultrasound25; this was based upon a better quality of life in the CTA group owing to lower risks of 
flap loss and fat necrosis. Further, they stated that provide CTA reduced operating time by more 
than 21 minutes then it “would always be cost-effective”. We have shown a significant and clinically 
important reduction in operating time which satisfies this condition. Further, if the cost per minute to 
run an operating theatre for a DIEP flap breast reconstruction were $53 in the USA57 or £11.3 in 
the UK, then by mapping we could save $2862 in the USA (95% CI $159, $5565) and £610 in the 
UK (95% CI £34, £1187), per patient. The per-procedure cost of a mapping CTA is $1562 in the 
USA and £60 in the UK. Therefore, with approximately 833 women undergoing free flap breast 
reconstruction per year in the UK (most of whom receive a DIEP flap)18, the potential cost savings 
per annum is approximately £0.5million. However, differences in the observed operating time 
between groups could also be explained by methodological biases or confounding variables, both 
of which are certainly present in the included studies. For those wishing to setup a perforator 
mapping service, we provide the scanning protocols for included studies in Appendix 1 
(supplementary online material). We invite further prospective research and economic analyses 
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into the potential improved cost utility58 of perforator mapping prior to DIEP flap breast 
reconstruction; ideally, these would be investigated in randomised trials.  
 
The benefits of perforator mapping must be weighed against the potential risks of medical imaging. 
Safety is of paramount importance and whilst ultrasound may be inferior to CTA/MRA in many 
ways, ultrasound remains popular because it is universally considered to be safe. Conversely, a 
typical CTA of the lower abdominal wall delivers 6-10 millisieverts (mSv), which does incur a 
statistically small but significantly increased risk of developing a de-novo cancer59,60. Rozen 
extrapolated this to infer that approximately 1 in 1050 women would develop an extra cancer 
attributable to mapping CTA (at 8.18mSv)61. Whilst magnetic resonance imaging does not pose 
any biological risk62, there are absolute contra-indications (metal in the eyes or brain given the risk 
of haemorrhage or visual loss respectively, and implants which are not “MR-safe” given the risk of 
burns or dysfunction), relative contra-indications (such as pregnancy63 and claustrophobia) and 
common side effects such as nausea, vertigo and temporary neuro-behavioural changes. 
Intravenous gadolinium was used in all included articles and provides the chief unpredictable risk 
for patients; gadolinium shorten the T1, improving fluid signal albeit not a ‘contrast medium’ in the 
strictest sense. Whilst old formulations of gadolinium conferred a small risk of nephrogenic 
systemic fibrosis owing to Gd3+ deposition, subsequent formulations based on a stronger chelator 
(DTPA) have all-but eliminated this concern. All current gadolinium based agents pose a dose-
dependent risk of adverse reaction with 1 in 100 being affected; most are transient hypersensitivity 
reactions but there is a 3 in 10,000 risk of death from anaphylaxis, typically affecting women with 
drug hypersensitivities.64 Therefore, whilst CTA and MRA may provide more useful information 
than ultrasound, there are risks which must be considered. To better explore this topic, we 
recommend a systematic review and meta-analysis of the diagnostic accuracy of CTA versus MRA 
for the identification of the dominant perforator in unilateral DIEP flap breast reconstruction. Once 
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Heterogeneity in the outcomes is important to consider because observed differences in the 
outcome may derive from statistical and/or clinical differences, which in-turn may confound the 
outcome. Regarding the differences in operative time associated with perforator mapping (Figure 
2) - heterogeneity may explain this difference, with baseline between-group differences favouring 
the mapping group, for example the mapping group may more: slimmer patients in which flap 
harvest is easier; patients operated on by senior (and so efficient) surgeons; immediate 
reconstructions which are quicker because the breast pocket and recipient vessel dissections may 
be less hostile, etc. It is likely there are systematic differences between studies because there are 
outliers in the meta-analyses (Figures 2 and 3) but the origin is unclear. Alternatively, the observed 
superiority of mapping may be due to statistical heterogeneity, which is high as represented by the 
I2 statistic and other factors, given that the original estimates were not adjusted for potential 
confounders. All such methodological biases were observed in the included studies, as depicted in 
the traffic light system alongside each forest plot. Whilst we used a random-effects model to 
generate conservative estimates and better accommodate the observed heterogeneity, readers 
should be cautious interpreting our data as we feel that the data is most useful for hypothesis 
genesis, rather than decision-making. As three articles (Table 1) did not detail the parameters of 




We have shown that the quality of evidence regarding perforator mapping for DIEP flap breast 
reconstruction is poor and as such, our findings have limited external validity. Whilst our review 
suggests that preoperative perforator mapping in DIEP flap breast reconstruction reduces 
operating time and morbidity, which is consistent with the evolving literature, we conclude that 
higher quality data is needed from well-designed and conducted randomised trials. 
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Figure 1. PRISMA flowchart 
 
 
Figure 2 – Mean Difference in Operating Time. Forest plot showing that preoperative mapping 
by CTA or MRA significantly reduces operating time of unilateral DIEP flap breast reconstruction, 
compared to no mapping alongside the risk of methodological bias assessments. 
 
Figure 3 – Mean Difference in Operating Time. Forest plot showing that preoperative CTA is 
preferable to Ultrasound for reducing the operative time of unilateral DIEP flap breast 
reconstruction, alongside the risk of methodological bias assessments. 
 
Figure 4 - Risk of Total Flap Failure. Forest plot showing no evidence of a difference in the risk 
of total flap failure for studies comparing mapping by CTA and ultrasound in unilateral DIEP flap 
breast reconstruction, alongside the risk of methodological bias assessments. 
 
Figure 5 - Risk of Partial Flap Failure. Forest plot showing that preoperative mapping by CTA 
significantly reduces the risk of partial flap failure compared to ultrasound in unilateral DIEP flap 
breast reconstruction, alongside the risk of methodological bias assessments. 
 
Figure 6 - Risk of bias summary. Review authors' judgements about the risk of bias. Green 
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Table 1. Study characteristics for women undergoing DIEP flap breast reconstruction. Details of each study’s imaging parameters can be found in 














: delayed  
Unilateral: 
bilateral Method #1 Method #2 
Casey 
200942 USA Retrospective 213 52 Unknown 139:74 
Handheld doppler ultrasound performed 
and interpreted by unknown operator(s) 
CT angiography (64-row detector); image 
reconstruction and interpretation were not 
described  
Fansa 
201137 Germany Retrospective 21 54 Unknown 21:0 No mapping 
CT angiography (64-row detector); image 





Spain Mixed 70 48 0:70 0:70 Handheld doppler ultrasound performed and interpreted by unknown operator(s) 
CT angiography (16-row detector); images were 
reconstructed and interpreted by a radiologist    
Ghattuara 
201051 UK Retrospective 100 47 Unknown 74:26 No mapping 
CT angiography (32-row detector); images were 






63 54 Unknown Unknown 
Handheld doppler ultrasound performed 
and interpreted by the operating surgeon 
using an 8MHz probe 
CT angiography (16- or 42-row detector); images 
were reconstructed and interpreted by one 
radiologist    
Malhotra 
201321 UK Retrospective 200 49 1:1 Unknown 
Phillips iU22 xMATRIX 
 (8-15MHz) ultrasound performed by an 
unknown operator. Images reported by one 
radiologist 
CT angiography (64-row detector); images were 
reconstructed and interpreted by one radiologist    
Minqiang 
201035 China Mixed 56 
Unknown Unknown Unknown Doppler sonography performed and interpreted by unknown operator(s) 
CT angiography (64-row detector); image 
reconstruction and interpretation were not 
described 
O'Connor 
201636 UK Retrospective 540 
Unknown 229:246 36:29 Handheld doppler ultrasound performed and interpreted by unknown operator(s) CTA methodology not described 
Rozen 
200845 Australia Mixed 88 
Unknown Unknown 9:2 Doppler ultrasound performed and interpreted by unknown operator(s) 
CT angiography (64-row detector); images were 
reconstructed but how they were interpreted is not 
described 
Schaverien 
201146 UK Retrospective 119 49 53:66 6:1 No mapping 
MRI angiography (1.5 Tesla) ; image reconstruction 
and interpretation were not described 
Smit 
200947 Sweden Retrospective 138 50 ~5:8 ~5:1 
Doppler ultrasound performed and 
interpreted by unknown operator(s) 
CT angiography (16-row detector); image 
reconstruction and interpretation were not 
described 
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Tong 
201248 USA Retrospective 69 49 Unknown Unknown No mapping 
CT angiography (64-row detector); images were 
reconstructed by unknown operator(s) and were 
interpreted by the operating surgeon. 
Uppal 
200949 Belgium Prospective 34 
Unknown Unclear Unclear Duplex ultrasonography performed and interpreted by unknown operator(s) CTA methodology not described 
Vargas 
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Figure 2 - Mapping v no mapping.png 
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Figure 3 - Op time CT v US.png 
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Figure 4 - total flap failure.png 
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Figure 5 - partial flap failure.png 
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